Login/Sign Up

MRP ₹17370
(Inclusive of all Taxes)
₹2084.4 Cashback (12%)
Fulvetraz 250mg Injection 5 ml is used to treat breast cancer in postmenopausal women. It contains Fulvestrant, which works by inhibiting some of the actions of estrogen (female sex hormone which may help cancer cells grow in women with breast cancer) and reducing the amount that is in the body. Thus, it helps in reducing breast cancer tumour growth. In some cases, Fulvetraz 250mg Injection 5 ml may cause certain common side effects such as injection site reactions like pain and/or inflammation, weakness, nausea, tiredness, headache or joint and musculoskeletal pain.
Provide Delivery Location
About Fulvetraz 250mg Injection 5 ml
Fulvetraz 250mg Injection 5 ml belongs to the class of estrogen blockers used to treat breast cancer in postmenopausal women. Breast cancer is a type of cancer that develops when the breast cells begin to grow abnormally.
Fulvetraz 250mg Injection 5 ml contains Fulvestrant, which works by inhibiting some of the actions of estrogen (female sex hormone which may help cancer cells grow in women with breast cancer) and reducing the amount that is in the body. Thus, it helps in reducing breast cancer tumour growth.
Fulvetraz 250mg Injection 5 ml will be administered by a healthcare professional; do not self-administer. In some cases, Fulvetraz 250mg Injection 5 ml may cause certain common side effects such as injection site reactions like pain and/or inflammation, weakness, nausea, tiredness, headache or joint and musculoskeletal pain. Most of these side effects of Fulvetraz 250mg Injection 5 ml do not require medical attention and gradually resolve over time. However, if these side effects persist or worsen, please consult your doctor.
If you are allergic to Fulvestrant or any other medicines, please tell your doctor. Fulvetraz 250mg Injection 5 ml is not recommended for pregnant women as it may harm an unborn baby. Fulvetraz 250mg Injection 5 ml is contraindicated for use during lactation. Avoid alcohol consumption while receiving Fulvetraz 250mg Injection 5 ml. Avoid driving or operating machinery if you feel tired or weak after receiving Fulvetraz 250mg Injection 5 ml.
Uses of Fulvetraz 250mg Injection 5 ml
Fulvetraz 250mg Injection 5 ml is used in the treatment of Breast cancer in postmenopausal women. The detailed uses of Fulvetraz 250mg Injection 5 ml are as follows:

Have a query?
Directions for Use
Medicinal Benefits
Fulvetraz 250mg Injection 5 ml contains Fulvestrant, used to treat breast cancer in postmenopausal women. Additionally, Fulvetraz 250mg Injection 5 ml may be used in combination with palbociclib to treat women with a type of breast cancer called hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer that is locally advanced or has spread to other parts of the body (metastatic).
How Fulvetraz 250mg Injection 5 ml Works
Storage
What if I have taken an overdose of Fulvetraz 250mg Injection 5 ml
Drug Warnings
If you are allergic to Fulvestrant or any other medicines, please tell your doctor. Fulvetraz 250mg Injection 5 ml is not recommended for pregnant women as it may harm an unborn baby. Using effective contraception while being treated with Fulvetraz 250mg Injection 5 ml and for two years after the last dose is advised. Fulvetraz 250mg Injection 5 ml is contraindicated for use during lactation. Avoid alcohol consumption while receiving Fulvetraz 250mg Injection 5 ml. Avoid driving or operating machinery if you feel tired or weak after receiving Fulvetraz 250mg Injection 5 ml.
Drug-Drug Interactions
Login/Sign Up
Drug-Food Interactions
Login/Sign Up
Diet & Lifestyle Advise
Habit Forming
Therapeutic Class

by Others
by Others
by Others
by Others
by Others
Alcohol
Caution
Avoid alcohol consumption while receiving this medicine. If you have any concerns, please discuss them with your doctor.
Pregnancy
Unsafe
Fulvetraz 250mg Injection 5 ml is not recommended for use during pregnancy as it may harm the unborn baby. You are advised to use effective contraception while being treated with Fulvetraz 250mg Injection 5 ml and for two years after your last dose.
Breast Feeding
Unsafe
Fulvetraz 250mg Injection 5 ml is contraindicated for use during lactation, or you are recommended to avoid breastfeeding while on treatment with Fulvetraz 250mg Injection 5 ml.
Driving
Safe if prescribed
Fulvetraz 250mg Injection 5 ml usually does not affect your ability to drive or operate machinery. However, avoid driving or operating machinery if you feel tired or weak after receiving Fulvetraz 250mg Injection 5 ml.
Liver
Caution
Fulvetraz 250mg Injection 5 ml is not recommended for patients with severe liver problems. Therefore, if you have liver problems, inform your doctor before receiving Fulvetraz 250mg Injection 5 ml.
Kidney
Caution
If you have kidney problems, inform your doctor before receiving Fulvetraz 250mg Injection 5 ml.
Children
Unsafe
Fulvetraz 250mg Injection 5 ml is not recommended for children and adolescents below 18 years of age.
Heart
Please inform your doctor if you have any pre-existing heart problems before using Fulvetraz 250mg Injection 5 ml. Your doctor will prescribe Fulvetraz 250mg Injection 5 ml if the benefits outweigh the risk.
Geriatrics
Safe if prescribed
Fulvetraz 250mg Injection 5 ml is generally considered safe when used under medical supervision in geriatric patients; however, significant precautions should be taken due to age-related sensitivities.
Fulvetraz 250mg Injection 5 ml is used to treat Breast cancer in postmenopausal women.
Fulvetraz 250mg Injection 5 ml contains Fulvestrant which works by inhibiting some of the actions of estrogen (female sex hormone) and reducing the amount that is in the body. Thus, it helps in reducing breast cancer tumour growth.
Fulvetraz 250mg Injection 5 ml is not recommended for patients with severe liver problems. Therefore, if you have any liver problems, inform your doctor before receiving Fulvetraz 250mg Injection 5 ml.
Fulvetraz 250mg Injection 5 ml may cause weakness or tiredness as a common side effect. However, if weakness persists or worsens, please consult your doctor.
Fulvetraz 250mg Injection 5 ml contains Fulvestrant, which belongs to a class of medications called estrogen receptor antagonists. It helps to slow or stop the growth of specific breast tumours that depend on estrogen (a female sex hormone) to grow.
Fulvetraz 250mg Injection 5 ml is administered as a liquid injection into a muscle in the buttocks by a doctor in a medical setting. It is typically injected slowly over 1 to 2 minutes. For the first three doses, you will receive an injection every two weeks (on days 1, 15, and 29). After that, it is usually given once a month. Your doctor will determine the exact schedule based on your condition and how you respond to the medication. The injection will be given as two separate shots (one in each buttock). Please do not self-administer it.
Fulvetraz 250mg Injection 5 ml may cause common side effects, such as injection site reactions like pain and inflammation, weakness, nausea, tiredness, headache, or joint and musculoskeletal pain in some individuals. Most of these side effects of Fulvetraz 250mg Injection 5 ml do not require medical attention and gradually resolve over time. However, if these side effects persist or worsen, please consult your doctor.
Country of origin
Manufacturer/Marketer address
Keep Refrigerated. Do not freeze.Prepaid payment required.
We provide you with authentic, trustworthy and relevant information
Buy best Neoplastic Disorders products by
Intas Pharmaceuticals Ltd
Dr Reddy's Laboratories Ltd
Celon Laboratories Pvt Ltd
Natco Pharma Ltd
Cipla Ltd
Adley Formulations
Sun Pharmaceutical Industries Ltd
Admac Lifesciences(Oncology)
BDR Pharmaceuticals Internationals Pvt Ltd
Glenmark Pharmaceuticals Ltd
Halsted Pharma Pvt Ltd
Neon Laboratories Ltd
Alkem Laboratories Ltd
United Biotech Pvt Ltd
Samarth Life Sciences Pvt Ltd
Emcure Pharmaceuticals Ltd
Zydus Cadila
Zydus Healthcare Ltd
GLS Pharma Ltd
Mylan Pharmaceuticals Pvt Ltd
Axiommax Oncology Pvt Ltd
Hetero Drugs Ltd
Hetero Healthcare Pvt Ltd
Fresenius Kabi India Pvt Ltd
Pfizer Ltd
Torrent Pharmaceuticals Ltd
Getwell Life Sciences India Pvt Ltd
Cadila Healthcare Ltd
Khandelwal Laboratories Pvt Ltd
Novartis India Ltd
Lupin Ltd
Therdose Pharma Pvt Ltd
Adley Pharmaceuticals Ltd
Aureate Healthcare
RPG Life Sciences Ltd
Abbott India Ltd
Biochem Pharmaceutical Industries Ltd
Delarc Pharmaceuticals Pvt Ltd
Zee Laboratories Ltd
Shilpa Medicare Ltd
Wembrace Biopharma Pvt Ltd
Aimcad Biotech Pvt Ltd
Amps Biotech Biotech Pvt Ltd
Msn Laboratories Pvt Ltd
Reliance Formulation Pvt Ltd
Astra Zeneca Pharma India Ltd
Getwell Oncology Pvt Ltd
Allieva Pharma Pvt Ltd
Getwell Pharmaceutical Pvt Ltd
MEDICAMEN BIOTECH LTD
Bhardwaj India Pvt Ltd
Caitlin Oncology
Del Trade International Pvt Ltd
Medaegis Biotek Pvt Ltd
Medion Biotech Pvt Ltd
Panacea Biotec Ltd
Cadila Pharmaceuticals Ltd
Dabur India Ltd
Lucien Life Sciences
Oncostar Pharma Pvt Ltd
Sarabhai Chemicals (India) Pvt Ltd
Bangalore Pharmaceutical and Research Laboratory Pvt Ltd (BPRL)
Cytogen
Symbion Lifescience
Vhb Life Sciences Inc
Zuvius Lifesciences Pvt Ltd
Amneal Healthcare Pvt Ltd
Ipca Laboratories Ltd
Miracalus Pharma Pvt Ltd
Eli Lilly and Company (India) Pvt Ltd
Hilfen Pharmaceuticals Pvt Ltd
Medicamen Biotech Ltd
Adley Oncology
Admac Pharma Ltd
Bruck Pharma Pvt Ltd
Eris Life Sciences Ltd
Johnson & Johnson Pvt Ltd
Maximal Healthcare Pvt Ltd
Reliance Life Sciences Pvt Ltd
Sayre Therapeutics Pvt Ltd
Akumentis Healthcare Ltd
Biocon Ltd
Caitlin Biotech Pvt Ltd
Ferring Pharmaceuticals Pvt Ltd
Fresenius Kabi Oncology Ltd
Zuventus Healthcare Ltd
Astellas Pharma India Pvt Ltd
Boehringer Ingelheim India Pvt Ltd
Mankind Pharma Pvt Ltd
Roche Diagnostics India Pvt Ltd
Selway Lifesciences Pvt Ltd
Trikem Remedies Llp
Aprazer Healthcare Pvt Ltd
Aureate Pharma
Caitlin Life Care
Corona Remedies Pvt Ltd
Eisai Pharmaceuticals India Pvt Ltd
GlaxoSmithKline Pharmaceuticals Ltd
Gynofem Healthcare Pvt Ltd
Hillrock Biotech Pvt Ltd